Key result
Review outlines customizable genetic circuits using RNA-binding proteins to target viral RNA for degradation.
Why the study?
Viral infections are difficult to manage with drugs due to high mutation rates and host ribosome hijacking, leaving few therapeutic options.
The paper outlines a synthetic biology approach using genetic circuits and RNA-binding proteins to target and degrade viral RNA.
May guide RNA-targeting circuit design for antivirals; hypothesis-generating and should not yet change practice.
Advances in synthetic biology have led to the design of biological parts that can be assembled in different ways to perform specific functions. For example, genetic circuits can be designed to execute specific therapeutic functions, including gene therapy or targeted detection and the destruction of invading viruses. Viral infections are difficult to manage through drug treatment. Due to their high mutation rates and their ability to hijack the host's ribosomes to make viral proteins, very few therapeutic options are available. One approach to addressing this problem is to disrupt the process of converting viral RNA into proteins, thereby disrupting the mechanism for assembling new viral particles that could infect other cells. This can be done by ensuring precise control over the abundance of viral RNA (vRNA) inside host cells by designing biological circuits to target vRNA for degradation. RNA-binding proteins (RBPs) have become important biological devices in regulating RNA processing. Incorporating naturally upregulated RBPs into a gene circuit could be advantageous because such a circuit could mimic the natural pathway for RNA degradation. This review highlights the process of viral RNA degradation and different approaches to designing genetic circuits. We also provide a customizable template for designing genetic circuits that utilize RBPs as transcription activators for viral RNA degradation, with the overall goal of taking advantage of the natural functions of RBPs in host cells to activate targeted viral RNA degradation.
No takes yet. Share an insight, caveat, or question.
Bello et al. (2023) conducted a review in Viral infections. Genetic circuits utilizing RNA-binding proteins was evaluated. This review provides a customizable template for designing genetic circuits that utilize RNA-binding proteins as transcription activators to target viral RNA for degradation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: